armed with an arsenal of innovative drugs and therapies. Several homegrown giants are not only tackling the diabetes crisis within the country, but also making waves on the international stage, ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry ... It hopes constant innovation will help it navigate the uncertainties to come from the US, the world's ...

is looking to take advantage of conducive policies, demographic and digital talent, in making India play a pivotal role in advancing global health for all.

"A focus on research excellence and innovation will position India as a global hub for high-quality, affordable pharmaceuticals. Collaboration between policymakers, academia and industry ...

The Pharma sector outperformed in 2024, gaining 29%, driven by resilience to macro challenges, US FDA resolutions, and ...

OPPI represents research-based pharmaceutical companies, including AstraZeneca, Novartis and Merck, in India. Besides, strengthened regulatory frameworks will enable the swift adoption of innovative ...

“Innovent is delighted to partner with Mankind Pharma to introduce our innovative PD-1 inhibitor sintilimab in India, providing new hope for patients battling various forms of cancer. Leveraging ...

"A focus on research excellence and innovation will position India as a global hub for high-quality, affordable pharmaceuticals. Collaboration between policymakers, academia and industry ...

“This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient access to innovative therapeutic options ... Cancer has become a major health concern in ...

We will file for regulatory approval in India early next year and complete all mandatory regulatory processes, including Mankind Pharma conducting a phase 3 clinical trial for successful approval ...

we will be filing for its regulatory approval in India and complete all mandatory regulatory processes, including the conducting of a phase 3 clinical trial by Mankind Pharma for its successful ...